-
Most Popular
Earnings Reports
SYBX Stock Earnings: Synlogic Beats EPS for Q2 2024
SYBX stock results show that Synlogic beat analyst estimates for earnings per share the second quarter of 2024.
GLUE Stock Earnings: Monte Rosa Therapeutics Beats EPS, Beats Revenue for Q2 2024
GLUE stock results show that Monte Rosa Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
CABA Stock Earnings: Cabaletta Bio Misses EPS for Q2 2024
CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the second quarter of 2024.
CGEM Stock Earnings: Cullinan Therapeutics Misses EPS for Q2 2024
CGEM stock results show that Cullinan Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
HOWL Stock Earnings: Werewolf Therapeutics Misses EPS, Beats Revenue for Q2 2024
HOWL stock results show that Werewolf Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
CARM Stock Earnings: CARISMA Therapeutics Beats EPS, Beats Revenue for Q2 2024
CARM stock results show that CARISMA Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
XLO Stock Earnings: Xilio Therapeutics Misses EPS for Q2 2024
XLO stock results show that Xilio Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
TRML Stock Earnings: Tourmaline Bio Beats EPS for Q2 2024
TRML stock results show that Tourmaline Bio beat analyst estimates for earnings per share the second quarter of 2024.
CQP Stock Earnings: Cheniere Energy Partners Beats EPS, Misses Revenue for Q2 2024
CQP stock results show that Cheniere Energy Partners beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
IMKTA Stock Earnings: Ingles Markets Reported Results for Q3 2024
Ingles Markets just reported results for the third quarter of 2024.
GANX Stock Earnings: Gain Therapeutics Misses EPS for Q2 2024
GANX stock results show that Gain Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
ENG Stock Earnings: ENGlobal Reported Results for Q2 2024
ENGlobal just reported results for the second quarter of 2024.
IPSC Stock Earnings: Century Therapeutics Beats EPS for Q2 2024
IPSC stock results show that Century Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
CGON Stock Earnings: CG Oncology Beats EPS for Q2 2024
CGON stock results show that CG Oncology beat analyst estimates for earnings per share the second quarter of 2024.
THRD Stock Earnings: Third Harmonic Bio Beats EPS for Q2 2024
THRD stock results show that Third Harmonic Bio beat analyst estimates for earnings per share the second quarter of 2024.
TOELY Stock Earnings: Tokyo Electron Reported Results for Q1 2025
Tokyo Electron just reported results for the first quarter of 2025.
VERA Stock Earnings: Vera Therapeutics Misses EPS for Q2 2024
VERA stock results show that Vera Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
REPL Stock Earnings: Replimune Group Beats EPS for Q1 2025
REPL stock results show that Replimune Group beat analyst estimates for earnings per share the first quarter of 2025.
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024
APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
